HAROLD JACOB - 23 Jan 2024 Form 4 Insider Report for NanoVibronix, Inc. (NAOV)

Role
Chief Medical Officer, Director
Signature
/s/ Harold Jacob, MD
Issuer symbol
NAOV
Transactions as of
23 Jan 2024
Transactions value $
$0
Form type
4
Filing time
26 Feb 2024, 17:32:19 UTC
Previous filing
04 Dec 2023
Next filing
02 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAOV Option to Purchase Common Stock Award $0 +6,667 $0 6,667 23 Jan 2024 Common Stock 6,667 $0.9 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the option vested on January 23, 2024, in accordance with that certain option agreement entered into by and between the Issuer and the reporting person and the NanoVibronix, Inc. 2014 Long-Term Incentive Plan.